CLINICAL DEVELOPMENT OF BIOLOGICS APPROVED BY THE US FOOD AND DRUG ADMINISTRATION, 2003-2016

被引：0
|
作者：
Alexander, G. C. [1 ]
Ogasawara, K. [1 ]
Wiegand, D. [1 ]
Lin, D. H. [2 ]
Breder, C. D. [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Drug Safety & Effectiveness, Baltimore, MD USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.1237
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP343
引用
收藏
页码：S209 / S209
页数：1
相关论文
共 50 条
  • [11] RE: Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration
    Cherny, Nathan I.
    Dafni, Urani
    Bogaerts, Jan
    Latino, Nicola J.
    Pentheroudakis, George
    Douillard, Jean-Yves
    Tabernero, Josep
    Zielinski, Christoph
    Piccart, Martine J.
    de Vries, Elisabeth G. E.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (10):
  • [12] Readability of medication guides for Food and Drug Administration-approved biologics in dermatology
    Lau, Charles B.
    Smith, Gideon P.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 48 (04) : 388 - 389
  • [13] Role of US military research programs in the development of US Food and Drug Administration - Approved antimalarial drugs
    Kitchen, LW
    Vaughn, DW
    Skillman, DR
    CLINICAL INFECTIOUS DISEASES, 2006, 43 (01) : 67 - 71
  • [14] DRUGS APPROVED FOR CLINICAL USE BY FOOD AND DRUG ADMINISTRATION
    DEHAEN, P
    JOURNAL OF NEW DRUGS, 1965, 5 (06): : 358 - &
  • [15] DRUGS APPROVED FOR CLINICAL USE BY FOOD AND DRUG ADMINISTRATION
    DEHAEN, P
    JOURNAL OF NEW DRUGS, 1966, 6 (02): : 112 - &
  • [16] RE: Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration Response
    Tibau, Ariadna
    Molto, Consolacion
    Amir, Eitan
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (10):
  • [17] Innovation in Development of Dermatologic Drugs Approved by the US Food and Drug Administration Between 2012 and 2022
    Kamat, Samir
    Ungar, Benjamin
    Agarwal, Aneesh
    Wan, Joy
    Ross, Joseph S.
    Gupta, Ravi
    JAMA DERMATOLOGY, 2024, 160 (02) : 226 - 229
  • [18] Epidemiology and trend of US pediatric burn hospitalizations, 2003-2016
    Armstrong, Megan
    Wheeler, Krista K.
    Shi, Junxin
    Thakkar, Rajan K.
    Fabia, Renata B.
    Groner, Jonathan I.
    Noffsinger, Dana
    Giles, Sheila A.
    Xiang, Henry
    BURNS, 2021, 47 (03) : 551 - 559
  • [19] Patient Participation in Clinical Trials of Oncology Drugs and Biologics Preceding Approval by the US Food and Drug Administration
    Hutchinson, Nora
    Carlisle, Benjamin
    Doussau, Adelaide
    Bosan, Rafia
    Gumnit, Eli
    MacPherson, Amanda
    Fergusson, Dean A.
    Kimmelman, Jonathan
    JAMA NETWORK OPEN, 2021, 4 (05) : E2110456
  • [20] Pharmacokinetic Drug-Drug Interactions with Drugs Approved by the US Food and Drug Administration in 2020: Mechanistic Understanding and Clinical RecommendationsS
    Yu, Jingjing
    Wang, Yan
    Ragueneau-Majlessi, Isabelle
    DRUG METABOLISM AND DISPOSITION, 2022, 50 (01) : 1 - 7
12345